Smith E, Ottosson F, Hellstrand S, Ericson U, Orho-Melander M, Fernandez C, et al
Glucagon-like peptide-1 (GLP-1) receptor agonists have become widely prescribed medications for type 2 diabetes and weight management in the United States
The newly improved glucagon-dependent insulinotropic polypeptide/GLP-1 RAs result in more than 20% weight loss in a recent clinical trial ( GLP-1RAs may be appropriate in patients with a BMI of 25 or greater and does require a rigorous prospective study to further characterize the role of GLP-1RAs in the treatment of lymphedema
Which patients does the article say should talk to a gastroenterologist first
Sie binden an dieselben Rezeptoren wie das Darmhormon und aktivieren dieselben Signalwege, wirken aber strker und deutlich lnger, weil sie langsamer abgebaut werden
Initial weight loss in week 1 is usually water weight from reduced food intake and decreased stomach distention, typically 12 pounds